An argument in support of cost-effectiveness analysis in oncology.
D003362:Cost-Benefit Analysis; D006801:Humans; D008495:Medical Oncology / Q000191:economics*; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D014481:United States